Correlation Between Design Therapeutics and MediciNova
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and MediciNova, you can compare the effects of market volatilities on Design Therapeutics and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and MediciNova.
Diversification Opportunities for Design Therapeutics and MediciNova
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Design and MediciNova is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and MediciNova go up and down completely randomly.
Pair Corralation between Design Therapeutics and MediciNova
Given the investment horizon of 90 days Design Therapeutics is expected to generate 2.06 times more return on investment than MediciNova. However, Design Therapeutics is 2.06 times more volatile than MediciNova. It trades about -0.08 of its potential returns per unit of risk. MediciNova is currently generating about -0.2 per unit of risk. If you would invest 617.00 in Design Therapeutics on December 30, 2024 and sell it today you would lose (196.00) from holding Design Therapeutics or give up 31.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Design Therapeutics vs. MediciNova
Performance |
Timeline |
Design Therapeutics |
MediciNova |
Design Therapeutics and MediciNova Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Design Therapeutics and MediciNova
The main advantage of trading using opposite Design Therapeutics and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |